This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Katholieke Universiteit Leuven. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Michael Alexander Schmid: Innovator in Viral Research
Introduction
Michael Alexander Schmid is a notable inventor based in Lumino, Switzerland. He has made significant contributions to the field of viral research, particularly in the development of innovative vaccine strains.
Latest Patents
One of his key patents is the "Chimeric yellow fever ZIKA virus strain." This invention relates to chimeric yellow fever-Zika strains and their attenuated versions. The patent details a method wherein the nucleotide sequence encoding the signal sequence and prME protein of the yellow fever virus is replaced by a nucleotide sequence encoding the signal sequence and the prME protein of a Zika virus. This advancement holds promise for vaccine development and public health.
Career Highlights
Michael is affiliated with Katholieke Universiteit Leuven, where he engages in cutting-edge research. His work focuses on the intersection of virology and immunology, contributing to the understanding and treatment of viral diseases.
Collaborations
He has collaborated with notable colleagues such as Kai Dallmeier and Dieudonné Buh Kum, enhancing the scope and impact of his research through teamwork and shared expertise.
Conclusion
Michael Alexander Schmid's innovative work in developing chimeric virus strains exemplifies the potential of scientific research to address global health challenges. His contributions continue to influence the field of virology and vaccine development.